Search Results 981-990 of 16958 for pharmacogenetics
Mayo Clinic Oncology — Medical oncologists at Mayo Clinic offer innovative treatments for cancers of the organs, bones, muscles and connective tissues.
A phase II study to evaluate antitumor activity of oral cMET inhibitor INC280 in adult patients with EGFR wild-type, advanced non-small cell lung cancer (NSCLC) ...
Mayo Clinic scientists are working to improve the diagnosis and treatment of multiple endocrine neoplasia, type 2, also called MEN 2. Researchers study the ...
Kwon J, Pruden K, Mohseni MM. Rapidly developing, large pyogenic liver abscesses in the setting of pancreatic cancer. Proc (Bayl Univ Med Cent).
About this study. The purpose of this study is to assess the level of financial and health insurance literacy and financial distress in cancer patients ...
The purpose of this study is to examine the safety and efficacy of Ibrutinib administered in combination with bendamustine and rituximab in patients with ...
The purpose of this study is to develop a biorepository of blood samples from cancer patients participating in the Gemini (IRB 19-006717) protocol.
ROCHESTER, Minn. — A new drug has been shown to increase healing and regeneration of the liver after major surgery, according to a study published[...] ...
Those using antihypertensive or antiarrhythmic agents; Those with significant cardiopulmonary comorbidities (namely history of arrhythmia, coronary artery ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.